Latest Lead News

Neurizon Therapeutics has completed manufacturing three GMP registration batches of its lead ALS drug candidate NUZ-001 ahead of schedule, paving the way for FDA submissions and clinical trial enrollment.

Harmoney has secured a $15 million revolving debt facility from a major Australian bank, refinancing its previous loan at a significantly lower margin and underpinning future growth.

Regis Healthcare has agreed to sell two aged care homes in Far North Queensland to Ozcare, securing a $25 million pre-tax gain and signaling a strategic portfolio shift towards premium locations.

AdAlta Limited has received a $0.78 million Research and Development Tax Incentive refund for FY2025, using part of it to repay a Radium Capital loan and strengthening its cash position as it nears a key licensing milestone.

Argenica Therapeutics has demonstrated that its lead drug candidate ARG-007 does not interfere with the clot-busting agent tenecteplase, fulfilling a critical FDA requirement and advancing its stroke therapy development.

Pacific Edge appoints Simon Flood as chairman designate, aiming to leverage his global investment expertise to navigate Medicare reimbursement challenges for its bladder cancer diagnostic tests in the US.

QPM Energy Limited has announced a $30 million equity raise to support the development of its Isaac Power Station, advancing toward a final investment decision in March 2026 and commissioning by mid-2027. The funding package, complemented by a $113.7 million lease agreement and a $40 million convertible note, underpins a project poised to strengthen Queensland’s energy transition.

QPM Energy Limited has had its trading suspension lifted following the announcement of a strategic investment term sheet and a capital raising, signaling renewed momentum for the energy company.

QPM Energy has raised $30.3 million through an oversubscribed share placement and signed a $40 million convertible note term sheet, paving a clear funding path for its 112MW Isaac Power Station project.

BTC Health has reissued its Chairman’s Address with added financial details, highlighting a strategic shift towards diversified medical products and a strong start to FY26 with 36% revenue growth.

GreenTech Metals has successfully raised $5.2 million through a placement to fund the acquisition and exploration of its Munni Munni PGE-Cu-Ni Project in Western Australia, bolstered by key board and technical appointments.

Renegade Exploration has reported impressive high-grade gold, silver, and copper rock chip results from its Caisson Project in Nevada, reinforcing the project’s potential for significant mineralisation. These findings build on earlier discoveries and set the stage for expanded exploration activities.